Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China.
Department of Gynecology, Qilu Hospital of Shandong University, Jinan, China.
J Gynecol Oncol. 2020 Jul;31(4):e68. doi: 10.3802/jgo.2020.31.e68. Epub 2020 May 27.
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.
2019 年冠状病毒病（COVID-19）的爆发是由严重急性呼吸系统综合征冠状病毒 2 引起的，该病毒已在全球迅速传播。与一般人群相比，癌症患者感染冠状病毒的风险更高，并且更有可能出现严重的并发症。COVID-19 的传播不断增加，这给妇科恶性肿瘤患者的临床护理带来了挑战。应通过严格实施专门针对控制 COVID-19 传播的措施，协调一致地努力有秩序地管理妇科恶性肿瘤。我们根据在中国控制 COVID-19 大流行的经验制定了。我们建议根据当地 COVID-19 相关情况，结合分层和个体化的方式对妇科恶性肿瘤患者进行管理。医疗保健决策应在控制 COVID-19 大流行传播和及时诊断与治疗妇科肿瘤患者之间取得平衡。
